NA Proactive news snapshot: Mydecine Innovations, Revive Therapeutics, BlueRush, Psyence Group, Mirasol Resources ...

Mydecine Innovations Group Inc announced a new multi-year research collaboration with Johns Hopkins University School of Medicine to study psychedelic therapies. The five-year agreement will see Denver-based Mydecine working with the team at Johns Hopkins, led by Dr Matthew Johnson and the Behavioural Pharmacology Research Unit. In a statement, Mydecine told shareholders that the team has “extensive” experience working on clinical research related to the therapeutic use of psychedelics.  Revive Therapeutics Ltd told investors it has boosted its clinical-stage product pipeline by striking an exclusive license deal to advance medicinal mushroom Ganoderma lucidum compounds to treat cancer. The agreement was struck with Puerto Rico Science Technology and Research Trust (PRSTRT), representing Universidad Central del Caribe (UCC) and St. Jude Children’s Research Hospital (St. Jude) where researchers have linked compounds with anti-cancer activity, specifically against breast cancer. As a drug candidate, it could potentially treat the most aggressive types of breast cancers such as triple-negative and inflammatory, Revive noted. "We are very excited about the new addition to our clinical-stage product pipeline as part of our long-term strategy of unlocking the therapeutic potential of medicinal mushrooms such as psilocybin and Ganoderma lucidum to treat mental health, substance abuse and aggressive cancers," said Michael Frank, CEO of Revive Therapeutics in a statement. BlueRush Inc has announced a partnership with UK-based technology solutions provider Ngoar that will provide it with a foothold in the local market. The Toronto-based company said the partnership will give its IndiVideo platform access to the UK and Ngoar’s “impressive” client list which spans a wide range of industry sectors including banking, pharmaceuticals, retail and infrastructure. BlueRush will add interactive personalized video to Ngoar’s existing offering of enterprise software solutions and systems across the entire digital spectrum from bespoke software integration and digital transformation to banking platforms and cryptocurrency. "We are thrilled to establish our partnership with Ngoar which is our first partnership agreement in the United Kingdom," BlueRush CEO Steve Taylor said in a statement. Psyence Group Inc has introduced a premium range of functional mushroom products under the GOODMIND banner. The international biotechnology company with operations in South Africa described the GOODMIND formula as harnessing the power of adaptogens; non-toxic, non-psychoactive fungi, used for centuries in traditional medicine for their stress-relieving benefits. The product line was formulated to nourish the mind and elevate everyday life by enhancing mental capacity and the body’s ability to adapt to stress.  Mirasol Resources Ltd has told investors that Newcrest International has given notice to terminate its option and farm-in agreement at the company’s Altazor project in Chile.  However, it said the gold mining giant will continue exploring at the Gorbea project, also in Chile, with a drill program planned to start in the fourth quarter of 2021. In an update on the two high sulfidation epithermal (HSE) gold projects, Mirasol said Newcrest made the decision to focus its exploration efforts elsewhere in Chile, including at Gorbea. It said Newcrest has spent more than US$3 million on the Altazor project and highly prospective drill-ready targets have been identified, which now remain untested. ESE Entertainment Inc. said it will provide marketing services for the Porsche Esports Sprint Challenge Poland (PESCP) as it continues its marketing partnership with the Polish Automobile and Motorcycle Federation and the official Polish Digital Motorsport Championship. The Porsche Esports Sprint Challenge Poland is being organized by ESE, Ragnar Simulators and The Polish Automobile and Motorcycle federation. The tournament started on August 16 with the pre-qualifying phase. Eight drivers from each pre-qualifying round will be granted a spot in the championship. The main season is scheduled to start on September 9 at Hockenheimring and reach its closure on October 28 at Nordschleife. The format of each event will remain unchanged with 15-minute qualifying sessions followed by 2x25 minute races. MagicMed Industries purchaser Enveric Biosciences Inc, has released a letter to its shareholders ahead of its annual stockholder meeting and the closing of the MagicMed transaction. Enveric is a patient-focused biotechnology company developing novel therapeutic drugs to improve the quality of life for cancer patients. In late May, MagicMed announced it had entered into a definitive agreement for an all-stock transaction that would see it acquired by Enveric. American Resources Corporation announced that it has finalized its site selection to build its first commercial-scale rare earth element (REE) purification and isolation facility in Noblesville, Indiana. The Fishers, Indiana-based supplier of raw materials to the rapidly growing global infrastructure market, said its secured US site provides 6.9 acres of developable land. The company has a goal of scaling it into an 80,000 square foot facility for purifying and isolating rare earth and critical elements utilizing ligand assisted displacement (LAD) chromatography technology. “The Noblesville site is in an existing industrial area that provides access to commercial water and power, and is well located for convenient logistics,” said the company. BioPorto A/S has posted interim second-quarter results that saw strong sales of antibodies and research use only sales of its flagship NGAL Test, which provides an early risk assessment of acute kidney injury (AKI), a well-known complication that is common after surgeries such as kidney transplants and heart-bypass. For the period ended June 30, 2021, the in vitro diagnostics company, which is headquartered in Hellerup, Denmark said revenue from antibodies was up 118% and research use only sales of its proprietary NGAL Test in the US increased 84% in US dollars and 68% in Danish krone. The company revealed that in the first half of 2021, BioPorto’s revenue grew by 20% measured in US dollars and 11% when measured in Danish krone, driven by “strong sales” of antibodies and higher research use only sales of the NGAL Test in the US. DRDGOLD Limited has told investors that it expects to announce an "exceptional" improvement in full-year earnings per share (EPS) despite an increase in the number of shares in issue. In a trading statement, the South Africa mine tailings retreatment specialist said EPS for the year to end June are likely to be between 160.1 rand (R) cents and 176.5c, an increase of between 94% and 114% from the 82.5c reported for full year 2020. The mining group said the expected increases are notwithstanding the full-year impact of the issuance of 168,158,944 shares to Sibanye-Stillwater Limited on 22 January 2020. The weighted average number of ordinary shares for FY2021 increased by 11%. Medallion Resources Ltd, which is focused on rare-earth production, has boosted its board of directors with the addition of Daniel Mamadou and Gabriel Alonso-Mendoza. Both are active participants and investors in the rare earth space and bring extensive commercial and financial experience, the firm said. Mamadou is the founder and executive director of Singapore-based Welsbach Holdings, which invests in the discovery and development of metals and materials critical to the global energy transition. Before that he co-founded Talaxis Ltd, a subsidiary of Noble Group focused on the development of supply chains of technology metals and materials. Meanwhile, Alonso-Mendoza co-founded Amvest Capital Inc to support companies seeking growth capital within the natural resource sector. Throughout his career, he has raised and invested over $1 billion for companies in the mining and metals, oil and gas, and agriculture industries Manganese X Energy Corp. said it has entered into a 7-month marketing and consulting contract with Toronto-based marketing firm, North Equities Corp. North Equities Corp. specializes in various social media platforms and will be able to facilitate greater awareness and widespread dissemination of the company's news. In connection with the contract, the company will pay North Equities $112,000 and issue 325,000 stock options exercisable at $0.345, exercisable for a period of 2 months, and North Equities has agreed to a contractual lock-up of 6 months on the shares underlying the options. Canada Silver Cobalt Works Inc. said it has filed a preliminary short form base shelf prospectus with the securities commissions of each of the provinces of Canada except Québec. The base shelf prospectus, when final, will allow Canada Silver Cobalt and/or certain of its security holders to qualify the distribution by way of prospectus of up to $30 million of common shares, preference shares, subscription receipts, warrants, debt securities and units, or any combination thereof, from time to time during the 25-month period during which the shelf prospectus is effective. The specific terms of any future offering will be established in a prospectus supplement to the shelf prospectus, which supplement will be filed with the applicable Canadian securities regulatory authorities in connection with any such offering. KWESST Micro Systems Inc. said it has applied to the TSX Venture Exchange (TSXV) for the listing of 3,536,057 common share purchase warrants. The warrants were previously issued during the company's over-subscribed brokered private placement of 3,536,057 units, which closed on April 29, 2021. The listing of the warrants remains subject to certain conditions including the satisfaction of all of the conditions for a supplemental listing of securities on the TSXV and the approval of the TSXV. If approved, the listing will be effective after August 30, 2021, which is the expiry date of the applicable statutory four-month resale restriction the warrants are currently subject to. The warrants are governed by a warrant indenture between the Company and TSX Trust Company dated April 29, 2021. OTC Markets Group Inc., the operator of financial markets for 11,000 US and global securities, has announced that Northwest Copper Corp., a new company creating an exciting copper-gold pipeline in British Columbia, Canada, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. The OTCQX Market is designed for established, investor-focused US and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. Peter Bell, president & CEO of NorthWest said: "This is an important step for NorthWest by making share ownership easier for our US-based investors. Further, this allows an increased number of investors to participate in our growth and gives NorthWest increased access to capital."